ENT Clinic, University of Udine, Udine, Italy.
Head Neck. 2012 Dec;34(12):1810-6. doi: 10.1002/hed.21862. Epub 2011 Oct 3.
It can be confusing for clinicians to work their way through the tangle of pathologic terms used in surgical pathology reports to describe squamous abnormalities in laryngeal biopsies. After a brief review of the normal microscopic anatomy of the larynx and time-honored clinical designations for surface-based abnormalities, this report sorts pathologic changes into 2 groups: those changes that do not carry a premalignant potential (including squamous metaplasia, squamous hyperplasia, pseudoepitheliomatous hyperplasia, keratosis, and parakeratosis) and those that do (including dyskeratosis, laryngeal intraepithelial neoplasia [LIN], atypia, dysplasia, and carcinoma in situ). Generally, lesions in the first group do not require additional therapy or close follow-up; lesions in the second group, however, demand either some form of local therapy or close follow-up to monitor for the development of a more aggressive pathology.
对于临床医生来说,在外科病理学报告中描述喉部活检标本中的鳞状异常时,理解使用的病理学术语的复杂含义可能会感到困惑。在简要回顾了喉部的正常显微镜解剖结构以及基于表面的异常的传统临床命名后,本报告将病理学变化分为 2 组:一组不具有潜在恶性的变化(包括鳞状化生、鳞状增生、假上皮瘤样增生、角化和不全角化),另一组具有潜在恶性的变化(包括角化不良、喉上皮内瘤变[LIN]、不典型、发育不良和原位癌)。通常,第一组病变不需要额外的治疗或密切随访;然而,第二组病变需要某种形式的局部治疗或密切随访,以监测更具侵袭性的病理学的发展。